217 related articles for article (PubMed ID: 36935504)
1. Multi-omics to predict acute radiation esophagitis in patients with lung cancer treated with intensity-modulated radiation therapy.
Zheng X; Guo W; Wang Y; Zhang J; Zhang Y; Cheng C; Teng X; Lam S; Zhou T; Ma Z; Liu R; Wu H; Ge H; Cai J; Li B
Eur J Med Res; 2023 Mar; 28(1):126. PubMed ID: 36935504
[TBL] [Abstract][Full Text] [Related]
2. Dosiomics and radiomics improve the prediction of post-radiotherapy neutrophil-lymphocyte ratio in locally advanced non-small cell lung cancer.
Hou R; Xia W; Zhang C; Shao Y; Zhu X; Feng W; Zhang Q; Yu W; Fu X; Zhao J
Med Phys; 2024 Jan; 51(1):650-661. PubMed ID: 37963229
[TBL] [Abstract][Full Text] [Related]
3. Multi-view radiomics and dosiomics analysis with machine learning for predicting acute-phase weight loss in lung cancer patients treated with radiotherapy.
Lee SH; Han P; Hales RK; Voong KR; Noro K; Sugiyama S; Haller JW; McNutt TR; Lee J
Phys Med Biol; 2020 Sep; 65(19):195015. PubMed ID: 32235058
[TBL] [Abstract][Full Text] [Related]
4. Lung Subregion Partitioning by Incremental Dose Intervals Improves Omics-Based Prediction for Acute Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients.
Li B; Zheng X; Zhang J; Lam S; Guo W; Wang Y; Cui S; Teng X; Zhang Y; Ma Z; Zhou T; Lou Z; Meng L; Ge H; Cai J
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230812
[TBL] [Abstract][Full Text] [Related]
5. Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients.
Li B; Ren G; Guo W; Zhang J; Lam SK; Zheng X; Teng X; Wang Y; Yang Y; Dan Q; Meng L; Ma Z; Cheng C; Tao H; Lei H; Cai J; Ge H
Front Pharmacol; 2022; 13():971849. PubMed ID: 36199694
[No Abstract] [Full Text] [Related]
6. Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features.
Huang Y; Feng A; Lin Y; Gu H; Chen H; Wang H; Shao Y; Duan Y; Zhuo W; Xu Z
Radiat Oncol; 2022 Nov; 17(1):188. PubMed ID: 36397060
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of risk factors of radiation-induced toxicity in limited-stage small cell lung cancer treated with hypofractionated intensity-modulated radiotherapy].
Zhao JJ; Bi N; Zhang T; Wang JY; Deng L; Wang X; Chen DF; Dai JR; Wang LH
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):627-633. PubMed ID: 37462020
[No Abstract] [Full Text] [Related]
8. Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation.
Kraus KM; Oreshko M; Schnabel JA; Bernhardt D; Combs SE; Peeken JC
Lung Cancer; 2024 Mar; 189():107507. PubMed ID: 38394745
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapy.
Guo W; Li B; Xu W; Cheng C; Qiu C; Sam SK; Zhang J; Teng X; Meng L; Zheng X; Wang Y; Lou Z; Mao R; Lei H; Zhang Y; Zhou T; Li A; Cai J; Ge H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):39. PubMed ID: 38280037
[TBL] [Abstract][Full Text] [Related]
10. Dosiomics improves prediction of locoregional recurrence for intensity modulated radiotherapy treated head and neck cancer cases.
Wu A; Li Y; Qi M; Lu X; Jia Q; Guo F; Dai Z; Liu Y; Chen C; Zhou L; Song T
Oral Oncol; 2020 May; 104():104625. PubMed ID: 32151995
[TBL] [Abstract][Full Text] [Related]
11. A dosiomics model for prediction of radiation-induced acute skin toxicity in breast cancer patients: machine learning-based study for a closed bore linac.
Saadatmand P; Mahdavi SR; Nikoofar A; Jazaeri SZ; Ramandi FL; Esmaili G; Vejdani S
Eur J Med Res; 2024 May; 29(1):282. PubMed ID: 38735974
[TBL] [Abstract][Full Text] [Related]
12. Radiomics and dosiomics-based prediction of radiotherapy-induced xerostomia in head and neck cancer patients.
Abdollahi H; Dehesh T; Abdalvand N; Rahmim A
Int J Radiat Biol; 2023; 99(11):1669-1683. PubMed ID: 37171485
[TBL] [Abstract][Full Text] [Related]
13. Radiomics and Dosiomics Signature From Whole Lung Predicts Radiation Pneumonitis: A Model Development Study With Prospective External Validation and Decision-curve Analysis.
Zhang Z; Wang Z; Yan M; Yu J; Dekker A; Zhao L; Wee L
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):746-758. PubMed ID: 36031028
[TBL] [Abstract][Full Text] [Related]
14. CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients.
Huang Q; Yang C; Pang J; Zeng B; Yang P; Zhou R; Wu H; Shen L; Zhang R; Lou F; Jin Y; Abdilim A; Jin H; Zhang Z; Xie X
Front Oncol; 2023; 13():1168995. PubMed ID: 37954080
[TBL] [Abstract][Full Text] [Related]
15. Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
Yang SS; OuYang PY; Guo JG; Cai JJ; Zhang J; Peng QH; He Y; Zhang BY; Liu ZQ; Hu XF; Chen YF; Chen CY; Xie FY
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1291-1300. PubMed ID: 36462689
[TBL] [Abstract][Full Text] [Related]
16. Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition.
Kraus KM; Oreshko M; Bernhardt D; Combs SE; Peeken JC
Front Oncol; 2023; 13():1124592. PubMed ID: 37007119
[TBL] [Abstract][Full Text] [Related]
17. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
[TBL] [Abstract][Full Text] [Related]
18. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
Haslett K; Bayman N; Franks K; Groom N; Harden SV; Harris C; Hanna G; Harrow S; Hatton M; McCloskey P; McDonald F; Ryder WD; Faivre-Finn C
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1341-1348. PubMed ID: 33232772
[TBL] [Abstract][Full Text] [Related]
19. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.
Nie T; Chen Z; Cai J; Ai S; Xue X; Yuan M; Li C; Shi L; Liu Y; Verma V; Bi J; Han G; Yuan Z
Radiother Oncol; 2024 Jan; 190():110047. PubMed ID: 38070685
[TBL] [Abstract][Full Text] [Related]
20. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
